Phio pharmaceuticals corp. (PHIO)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11
ASSETS
Current assets:
Cash

13,284

6,934

8,709

10,816

12,746

14,879

-

-

-

3,581

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash and cash equivalents

-

-

-

-

-

-

3,240

5,315

2,606

-

5,416

7,702

10,205

12,906

2,379

3,832

4,192

5,117

4,035

5,986

6,580

8,496

5,130

11,911

9,010

11,390

6,847

8,587

19,643

5,127

6,278

7,575

357

503

Restricted cash

50

50

50

50

50

50

50

50

-

50

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

50

-

50

50

50

50

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

50

50

50

50

50

50

50

50

50

50

50

50

53

53

53

53

53

-

-

53

Short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,000

2,000

3,500

5,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

271

337

125

150

321

477

265

311

-

-

-

442

-

-

-

-

-

-

-

-

-

-

-

-

Short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,000

8,000

-

-

5,000

-

3,000

3,000

9,000

9,000

-

-

-

-

-

-

Due from Parent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

597

597

Prepaid expenses and other current assets

267

316

533

507

117

221

332

459

206

201

-

-

-

-

-

-

-

-

432

718

351

-

510

367

226

303

181

209

102

212

144

162

58

186

Total current assets

13,601

7,300

9,292

11,373

12,913

15,150

3,622

5,824

2,862

3,832

5,737

8,089

10,380

13,106

4,750

6,359

8,007

10,978

12,517

14,754

6,981

8,988

10,690

12,328

12,286

14,743

16,081

17,849

19,798

5,392

6,475

7,737

1,012

1,339

Right of use asset

484

511

538

565

592

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment, net

202

210

231

152

155

172

187

207

228

248

269

275

105

114

124

135

149

163

162

181

170

183

193

204

155

177

130

147

172

198

235

282

315

355

Notes receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

150

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

18

18

18

18

18

0

0

0

-

18

27

27

27

27

27

27

18

18

18

18

18

18

18

18

-

18

-

-

-

-

-

-

-

-

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18

-

0

-

2

2

-

-

-

-

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

-

-

-

Total assets

14,305

8,039

10,079

12,108

13,678

15,322

3,809

6,031

3,090

4,098

6,033

8,391

10,512

13,397

4,901

6,521

8,174

11,159

12,697

14,953

7,169

9,189

10,901

12,550

12,459

14,938

16,211

17,996

19,972

5,592

6,712

8,019

1,327

1,694

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

685

809

856

736

721

550

491

542

521

511

702

741

672

917

457

297

281

1,163

222

635

459

285

137

293

277

163

177

358

366

416

155

277

747

387

Accrued expenses and other current liabilities

1,143

964

1,076

1,098

703

1,194

1,568

2,217

2,002

1,754

1,901

1,713

1,593

1,625

1,408

1,256

940

1,106

1,443

1,187

1,097

1,002

958

682

1,024

1,795

1,018

913

1,126

767

877

610

537

544

Lease liability

109

107

104

102

92

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

47

61

78

89

118

147

239

464

491

370

468

797

816

Current maturities of capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

2

5

9

11

18

29

Total current liabilities

1,937

1,880

2,036

1,936

1,516

1,744

2,059

2,759

2,523

2,265

2,603

2,454

2,265

2,542

1,865

1,553

1,221

2,269

1,665

1,822

1,556

1,334

1,156

1,053

1,390

2,076

1,342

1,510

1,958

1,679

1,411

1,366

2,099

1,776

Lease liability, net of current portion

383

411

438

465

500

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,000

500

Deferred revenue, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

27

-

-

-

-

Capital lease obligations, net of current maturities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

5

5

Total liabilities

2,320

2,291

2,474

2,401

2,016

1,744

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,342

1,510

1,958

1,706

1,411

1,371

3,104

2,281

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Series A convertible preferred stock, $0.0001 par value, no shares authorized, issued or outstanding at December 31, 2015; 15,000 shares authorized and 5,110 shares issued and outstanding at December 31, 2014 (at liquidation value)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,771

9,896

-

-

-

-

-

Stockholders' equity:
Preferred stock, $0.0001 par value, 10,000,000 shares authorized

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

0

0

0

0

0

0

0

0

0

0

-

-

-

-

9,575

9,424

0

-

Common stock, $0.0001 par value, 100,000,000 shares authorized; 2,867,851 and 669,433 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

1

1

3

3

2

0

0

0

0

0

0

0

0

0

1

1

1

1

6

6

3

-

2

1

1

1

1

1

32

-

16

16

10

10

Additional paid-in capital

109,154

100,566

99,761

99,769

99,690

99,489

85,934

85,963

81,357

80,384

79,979

80,010

79,806

73,429

66,795

66,515

66,288

65,994

65,515

65,118

52,331

48,049

47,452

44,586

41,964

40,969

40,602

40,229

39,640

11,317

11,155

-

-

3,680

Accumulated deficit

-97,170

-94,819

-92,159

-90,065

-88,030

-85,911

-84,184

-82,691

-80,790

-78,551

-76,549

-74,073

-71,559

-66,099

-63,760

-61,548

-59,336

-57,105

-54,489

-51,993

-49,827

-46,882

-44,578

-42,372

-

-38,082

-

-

-

-

-

-

-

-

Deficit accumulated during the developmental stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40,366

-

35,574

33,515

31,554

17,157

15,445

-

-

4,277

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,009

4,416

-

Deficit accumulated during the developmental stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13,801

-6,203

-

Total stockholders' equity

11,985

5,748

7,605

9,707

11,662

13,578

1,750

3,272

567

1,833

3,430

5,937

8,247

10,855

3,036

4,968

6,953

8,890

11,032

13,131

2,528

2,745

4,723

6,562

6,219

4,942

7,048

6,715

8,118

-5,840

-4,274

-2,776

-1,777

-587

Total liabilities and stockholders' equity

14,305

8,039

10,079

12,108

13,678

15,322

3,809

6,031

3,090

4,098

6,033

8,391

10,512

13,397

4,901

6,521

8,174

11,159

12,697

14,953

7,169

9,189

10,901

12,550

12,459

14,938

16,211

17,996

19,972

5,592

6,712

8,019

1,327

1,694